Panacea Acquisition Corp. II

Panacea Acquisition Corp. II (Nasdaq: PANA) is a blank-check company focused on the healthcare and life sciences sector, sponsored by Panacea Capital Group. The vehicle completed its initial public offering in 2021, targeting merger candidates in therapeutics, medical technology, and related healthcare verticals. Its quarterly report on Form 10-Q, filed with the SEC on May 16, 2022 under accession number 0001213900-22-027075, reflects the company's status as an active search-stage SPAC at that time, still pursuing a definitive business combination. Visit SpacDesk and sign up for full access to PANA's filings, timeline, and comparable deal data.